Julian Gillmore

MD, PhD, University College London, US

Specializes in [Amyloidosis]

• Professor of Medicine University College London, Inflammation
• Pioneered research that transformed treatment paradigms across systemic amyloidosis, including a landmark 2001 Lancet paper on AA amyloidosis.
• Led major advances in AL and ATTR amyloidosis, including non-biopsy ATTR diagnosis criteria and the first in-human CRISPR-Cas9 trial.

tosprivacy